NDC 70710-1508 – Bosentan
Bosentan 32 mg/1 · Tablet, For Suspension · Oral
Product NDC70710-1508
Product details
- Brand name
- Bosentan
- Generic name
- Bosentan
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- Tablet, For Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA213981
- Marketed since
- February 17, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Endothelin Receptor Antagonist
Active ingredients
- Bosentan 32 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70710-1508-8 | 4 BLISTER PACK in 1 CARTON (70710-1508-8) / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK (70710-1508-7) | Feb 17, 2026 |
Other Bosentan products
- 68180-340 Bosentan 32 mg/1 · Tablet, For Suspension · Lupin Pharmaceuticals, Inc.
- 70771-1908 Bosentan 32 mg/1 · Tablet, For Suspension · Zydus Lifesciences Limited
- 0591-2511 Bosentan 62.5 mg/1 · Tablet, Film Coated · Actavis Pharma, Inc.
- 0591-2512 Bosentan 125 mg/1 · Tablet, Film Coated · Actavis Pharma, Inc.
- 47335-038 Bosentan 62.5 mg/1 · Tablet, Film Coated · Sun Pharmaceutical Industries, Inc.
- 47335-039 Bosentan 125 mg/1 · Tablet, Film Coated · Sun Pharmaceutical Industries, Inc.
- 70771-1017 Bosentan 62.5 mg/1 · Tablet · Zydus Lifesciences Limited
- 70771-1018 Bosentan 125 mg/1 · Tablet · Zydus Lifesciences Limited
- 68382-446 Bosentan 62.5 mg/1 · Tablet, Coated · Zydus Pharmaceuticals USA Inc.
- 68382-447 Bosentan 125 mg/1 · Tablet, Coated · Zydus Pharmaceuticals USA Inc.